Practical Guidelines for Multiplicity Adjustment in Clinical Trials
- 1 December 2000
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 21 (6), 527-539
- https://doi.org/10.1016/s0197-2456(00)00106-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Testing the Hypothesis that Matters for Multiple Primary EndpointsDrug Information Journal, 1996
- Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel DiseaseNew England Journal of Medicine, 1996
- Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)American Journal of Hypertension, 1996
- Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulationJournal of Clinical Epidemiology, 1996
- Multiple Comparisons with Control in a Single Experiment versus Separate Experiments: Why Do We Feel Differently?The American Statistician, 1995
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2The Lancet, 1988
- Multiple Range and Multiple F TestsBiometrics, 1955